Cargando…

Evidence-Based Practice Guideline for Surgical Treatment of Gastroesophageal Reflux Disease 2018

The prevalence of gastroesophageal reflux disease (GERD) is increasing in Korea, and physicians, including surgeons, have been focusing on its treatment. Indeed, in Korea, medical treatment using a proton pump inhibitor is the mainstream treatment for GERD, while awareness of surgical treatment is l...

Descripción completa

Detalles Bibliográficos
Autores principales: Seo, Ho Seok, Choi, Miyoung, Son, Sang-Yong, Kim, Min Gyu, Han, Dong-Seok, Lee, Han Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Gastric Cancer Association 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310769/
https://www.ncbi.nlm.nih.gov/pubmed/30607295
http://dx.doi.org/10.5230/jgc.2018.18.e41
_version_ 1783383492402348032
author Seo, Ho Seok
Choi, Miyoung
Son, Sang-Yong
Kim, Min Gyu
Han, Dong-Seok
Lee, Han Hong
author_facet Seo, Ho Seok
Choi, Miyoung
Son, Sang-Yong
Kim, Min Gyu
Han, Dong-Seok
Lee, Han Hong
author_sort Seo, Ho Seok
collection PubMed
description The prevalence of gastroesophageal reflux disease (GERD) is increasing in Korea, and physicians, including surgeons, have been focusing on its treatment. Indeed, in Korea, medical treatment using a proton pump inhibitor is the mainstream treatment for GERD, while awareness of surgical treatment is limited. Accordingly, to promote the understanding of surgical treatment for GERD, the Korean Anti-Reflux Surgery Study Group published the Evidence-Based Practice Guideline for the Surgical Treatment of GERD. The guideline consists of 2 sections: fundamental information such as the definition, symptoms, and diagnostic tools of GERD and a recommendation statement about its surgical treatment. The recommendations presented 5 debates regarding fundoplication: 1) comparison of the effectiveness of medical and surgical treatments, 2) effectiveness of surgical treatment in cases of refractory GERD, 3) effectiveness of surgical treatment of extraesophageal symptoms, 4) comparison of effectiveness between total and partial fundoplication, and 5) effectiveness of fundoplication in cases of hiatal hernia. The present guideline is the first to demonstrate the efficacy of the surgical treatment GERD in Korea.
format Online
Article
Text
id pubmed-6310769
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher The Korean Gastric Cancer Association
record_format MEDLINE/PubMed
spelling pubmed-63107692019-01-03 Evidence-Based Practice Guideline for Surgical Treatment of Gastroesophageal Reflux Disease 2018 Seo, Ho Seok Choi, Miyoung Son, Sang-Yong Kim, Min Gyu Han, Dong-Seok Lee, Han Hong J Gastric Cancer Special Article The prevalence of gastroesophageal reflux disease (GERD) is increasing in Korea, and physicians, including surgeons, have been focusing on its treatment. Indeed, in Korea, medical treatment using a proton pump inhibitor is the mainstream treatment for GERD, while awareness of surgical treatment is limited. Accordingly, to promote the understanding of surgical treatment for GERD, the Korean Anti-Reflux Surgery Study Group published the Evidence-Based Practice Guideline for the Surgical Treatment of GERD. The guideline consists of 2 sections: fundamental information such as the definition, symptoms, and diagnostic tools of GERD and a recommendation statement about its surgical treatment. The recommendations presented 5 debates regarding fundoplication: 1) comparison of the effectiveness of medical and surgical treatments, 2) effectiveness of surgical treatment in cases of refractory GERD, 3) effectiveness of surgical treatment of extraesophageal symptoms, 4) comparison of effectiveness between total and partial fundoplication, and 5) effectiveness of fundoplication in cases of hiatal hernia. The present guideline is the first to demonstrate the efficacy of the surgical treatment GERD in Korea. The Korean Gastric Cancer Association 2018-12 2018-12-27 /pmc/articles/PMC6310769/ /pubmed/30607295 http://dx.doi.org/10.5230/jgc.2018.18.e41 Text en Copyright © 2018. Korean Gastric Cancer Association https://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Special Article
Seo, Ho Seok
Choi, Miyoung
Son, Sang-Yong
Kim, Min Gyu
Han, Dong-Seok
Lee, Han Hong
Evidence-Based Practice Guideline for Surgical Treatment of Gastroesophageal Reflux Disease 2018
title Evidence-Based Practice Guideline for Surgical Treatment of Gastroesophageal Reflux Disease 2018
title_full Evidence-Based Practice Guideline for Surgical Treatment of Gastroesophageal Reflux Disease 2018
title_fullStr Evidence-Based Practice Guideline for Surgical Treatment of Gastroesophageal Reflux Disease 2018
title_full_unstemmed Evidence-Based Practice Guideline for Surgical Treatment of Gastroesophageal Reflux Disease 2018
title_short Evidence-Based Practice Guideline for Surgical Treatment of Gastroesophageal Reflux Disease 2018
title_sort evidence-based practice guideline for surgical treatment of gastroesophageal reflux disease 2018
topic Special Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310769/
https://www.ncbi.nlm.nih.gov/pubmed/30607295
http://dx.doi.org/10.5230/jgc.2018.18.e41
work_keys_str_mv AT seohoseok evidencebasedpracticeguidelineforsurgicaltreatmentofgastroesophagealrefluxdisease2018
AT choimiyoung evidencebasedpracticeguidelineforsurgicaltreatmentofgastroesophagealrefluxdisease2018
AT sonsangyong evidencebasedpracticeguidelineforsurgicaltreatmentofgastroesophagealrefluxdisease2018
AT kimmingyu evidencebasedpracticeguidelineforsurgicaltreatmentofgastroesophagealrefluxdisease2018
AT handongseok evidencebasedpracticeguidelineforsurgicaltreatmentofgastroesophagealrefluxdisease2018
AT leehanhong evidencebasedpracticeguidelineforsurgicaltreatmentofgastroesophagealrefluxdisease2018